Befejeződött1. fázis
A Study to Assess Distribution, Binding, and Retention of the Monoclonal Antibody Trontinemab in the Brain of Healthy Participants and Patients with Alzheimer’s Disease
Key facts
- Where
- Amsterdam, HollandiaSee the site
- Phase
- 1. fázis
Where in Hollandia
- Stichting Amsterdam UMCAmsterdam, HollandiaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- F. Hoffmann-La Roche AG
- Trial code
- EU 2023-509900-14-00
- Record updated
- 2026. június 18.